Completed PHASE1 INTERVENTIONAL 1-arm NCT00002923

KRN5500 in Treating Patients With Metastatic Solid Tumors

Phase I Evaluation of KRN5500 (NSC650426)

Sponsor: Barbara Ann Karmanos Cancer Institute

Conditions Unspecified Adult Solid Tumor, Protocol Specific

Interventions KRN5500

Updated 6 times since 2017 Last updated: Apr 24, 2014 Started: May 31, 1997 Primary completion: Jan 31, 2000 Completion: Oct 31, 2000

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Unspecified Adult Solid Tumor, Protocol Specific, this trial is completed. The trial is conducted by Barbara Ann Karmanos Cancer Institute and has accumulated 6 data snapshots since 1997. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

May 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Data source: Barbara Ann Karmanos Cancer Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Detroit, United States